Key facts
- This page summarizes Christopher S. Lynch's Form 4 filing for TENET HEALTHCARE CORP (THC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Jul 2026, 20:00.
Christopher S. Lynch - 27 Jul 2026 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)
- Reporting relationship
- Director
- Issuer ticker
- THC
- Reported as of
- 27 Jul 2026
- Net transaction value
- -$934,079
- SEC form
- 4
- Accepted by SEC
- 28 Jul 2026, 20:00:05 UTC
- Prior SEC filing
- 22 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- Chad J. Wiener, as Attorney-in-fact for Christopher S. Lynch
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Christopher S. Lynch filed Form 4 for TENET HEALTHCARE CORP (THC) on 28 Jul 2026.
Change
- Previous filing in this sequence was filed on 22 Jun 2026.
- Current net transaction value: -$934,079.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001452627
Primary reporting owner
Lynch Christopher S.
- Relationship
- Director
- Address
- 14201 DALLAS PARKWAY, DALLAS
- Signature
- Chad J. Wiener, as Attorney-in-fact for Christopher S. Lynch
- Signature date
- 28 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
THC
transaction
Common Stock
Sale
- Transaction value
- -$934,079
- Shares
- -3,837
- Change %
- -29%
- Price
- $243.44
- Shares after
- 9,568
- Date
- 27 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.